2018 Associate Sponsors

Personalis

2017 Executive Sponsors

Foundation Medicine
Mitra Biotech

2017 Associate Sponsors

Adaptive Biotechnologies
Affimed
Inovio
Personalis
SignalRX Pharmaceuticals
Vyriad

2017 Educational Partners

CRI
SITC

2017 Media Partners

Biocompare
BioPharm Insight
BioPharma Dive
CanBiotech
Clinical Leader
Life Science Leader
MNT
Pharmaceutical Online
Pharmalicensing
pharmaphorum
PharmaVOICE
SciDoc Publishers
Technology Networks

Who Should Attend

The program is designed for all size pharma/biotech companies and investors seeking to accelerate clinical trials in the emerging immuno-oncology space.

Large Pharma/Biopharma/Biotech responsible for:

  • R&D: Clinical Research/Development, Clinical Operations, Clinical Oncology, Cancer Immunotherapy, Immunology, Translational Research/Development/Medicine, Medical Affairs, R&D Innovation & Strategy, Biomarkers
  • Business Development: Corporate Venture, Licensing, Strategic Partnerships, Negotiations, Early-stage Collaboration, Commercial Innovation, External R&D

Investment Community:

  • Investment Firms
  • Venture Capitals
  • Banks/Financial Institutions
  • Foundation Capital

Academia & Research Organizations focusing on:

  • Immuno-Oncology
  • Immunotherapy
  • Oncology
  • Immunology
  • Immunobiology
  • Cancer Vaccines
  • Adoptive T-Cell Therapy
  • Clinical Research and Development

Solution Providers:

  • CROs
  • Consultants/Advisors
  • Law Firms
  • Technology/Medical Device Platforms

Our audience is as much a part of the event as our speaking faculty. Our ultimate goal is to foster a Summit environment that inspires positive change in immuno-oncology and support for all those involved in the movement. If you are interested in joining the speaking faculty or audience, please email us at Customer Service.